This webinar will focus on how C15:0 is being evaluated and used within functional and integrative practices today. Dr. Watson will review clinical considerations, dosing approaches, and patient response patterns to help you determine where Fatty15 may fit within existing care strategies.
What you’ll take away
✔ The science confirming C15:0 as an essential fatty acid
✔ Its role in cell membrane stability, metabolic balance, and inflammation resolution
✔ Clinical use cases and practitioner outcomes
✔ How Fatty15 fits into existing wellness and longevity protocols
✔ A straightforward way to introduce it to patients
About the Speaker
Dr. Stephanie Venn-Watson is Co-Founder and Co-CEO of Seraphina Therapeutics. A veterinary epidemiologist, she has worked with the World Health Organization, DARPA, and the U.S. Navy, and has authored more than 80 peer-reviewed scientific papers and holds 70+ patents.
Her discoveries on the health benefits of C15:0 have been featured by NPR Science Friday, BBC, NBC, and National Geographic, and are the focus of her best-selling Simon & Schuster book, The Longevity Nutrient.
Dr. Venn-Watson is a recipient of Fast Company’s World Changing Idea in Wellness, an Albert Schweitzer Fellow for Life, and a 2025 CNBC Changemaker.